Global Nanotechnology in Cancer Treatment Market Size, Status and Forecast 2020-2026

May 2020 | 99 pages | ID: G491980D7A0CEN
QYResearch

Abstracts

This report focuses on the global Nanotechnology in Cancer Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nanotechnology in Cancer Treatment development in North America, Europe, China and Japan.

The key players covered in this study

• Abbott Laboratories
• Combimatrix Corporation
• GE Healthcare
• Sigma-Tau Pharmaceuticals Inc.
• Johnson & Johnson
• Mallinckrodt Plc
• Merck & Company Inc.
• Nanosphere Inc.
• Pfizer, Inc.
• Celgene Corporation

Market segment by Type, the product can be split into

• Nanoparticles
• Nanorods
• Nanofibers
• Graphene
• Metal-Organic Frameworks
• Nanobiosensors
• Nanofluidic Devices
• Nanotools

Market segment by Application, split into

• Cancer Detection
• Imaging
• Drug Delivery
• Radiotherapy
• Immunotherapy
• Phototherapy

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan

The study objectives of this report are:

• To analyze global Nanotechnology in Cancer Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Nanotechnology in Cancer Treatment development in North America, Europe, China and Japan.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Nanotechnology in Cancer Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Nanotechnology in Cancer Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Nanotechnology in Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Nanoparticles
  1.4.3 Nanorods
  1.4.4 Nanofibers
  1.4.5 Graphene
  1.4.6 Metal-Organic Frameworks
  1.4.7 Nanobiosensors
  1.4.8 Nanofluidic Devices
  1.4.9 Nanotools
1.5 Market by Application
  1.5.1 Global Nanotechnology in Cancer Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Cancer Detection
  1.5.3 Imaging
  1.5.4 Drug Delivery
  1.5.5 Radiotherapy
  1.5.6 Immunotherapy
  1.5.7 Phototherapy
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Nanotechnology in Cancer Treatment Market Perspective (2015-2026)
2.2 Nanotechnology in Cancer Treatment Growth Trends by Regions
  2.2.1 Nanotechnology in Cancer Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Nanotechnology in Cancer Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Nanotechnology in Cancer Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Nanotechnology in Cancer Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Nanotechnology in Cancer Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Nanotechnology in Cancer Treatment Players by Market Size
  3.1.1 Global Top Nanotechnology in Cancer Treatment Players by Revenue (2015-2020)
  3.1.2 Global Nanotechnology in Cancer Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Nanotechnology in Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Nanotechnology in Cancer Treatment Market Concentration Ratio
  3.2.1 Global Nanotechnology in Cancer Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Nanotechnology in Cancer Treatment Revenue in 2019
3.3 Nanotechnology in Cancer Treatment Key Players Head office and Area Served
3.4 Key Players Nanotechnology in Cancer Treatment Product Solution and Service
3.5 Date of Enter into Nanotechnology in Cancer Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Nanotechnology in Cancer Treatment Historic Market Size by Type (2015-2020)
4.2 Global Nanotechnology in Cancer Treatment Forecasted Market Size by Type (2021-2026)

5 NANOTECHNOLOGY IN CANCER TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Nanotechnology in Cancer Treatment Market Size by Application (2015-2020)
5.2 Global Nanotechnology in Cancer Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Nanotechnology in Cancer Treatment Market Size (2015-2020)
6.2 Nanotechnology in Cancer Treatment Key Players in North America (2019-2020)
6.3 North America Nanotechnology in Cancer Treatment Market Size by Type (2015-2020)
6.4 North America Nanotechnology in Cancer Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Nanotechnology in Cancer Treatment Market Size (2015-2020)
7.2 Nanotechnology in Cancer Treatment Key Players in Europe (2019-2020)
7.3 Europe Nanotechnology in Cancer Treatment Market Size by Type (2015-2020)
7.4 Europe Nanotechnology in Cancer Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Nanotechnology in Cancer Treatment Market Size (2015-2020)
8.2 Nanotechnology in Cancer Treatment Key Players in China (2019-2020)
8.3 China Nanotechnology in Cancer Treatment Market Size by Type (2015-2020)
8.4 China Nanotechnology in Cancer Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Nanotechnology in Cancer Treatment Market Size (2015-2020)
9.2 Nanotechnology in Cancer Treatment Key Players in Japan (2019-2020)
9.3 Japan Nanotechnology in Cancer Treatment Market Size by Type (2015-2020)
9.4 Japan Nanotechnology in Cancer Treatment Market Size by Application (2015-2020)

10 KEY PLAYERS PROFILES

10.1 Abbott Laboratories
  10.1.1 Abbott Laboratories Company Details
  10.1.2 Abbott Laboratories Business Overview and Its Total Revenue
  10.1.3 Abbott Laboratories Nanotechnology in Cancer Treatment Introduction
  10.1.4 Abbott Laboratories Revenue in Nanotechnology in Cancer Treatment Business (2015-2020))
  10.1.5 Abbott Laboratories Recent Development
10.2 Combimatrix Corporation
  10.2.1 Combimatrix Corporation Company Details
  10.2.2 Combimatrix Corporation Business Overview and Its Total Revenue
  10.2.3 Combimatrix Corporation Nanotechnology in Cancer Treatment Introduction
  10.2.4 Combimatrix Corporation Revenue in Nanotechnology in Cancer Treatment Business (2015-2020)
  10.2.5 Combimatrix Corporation Recent Development
10.3 GE Healthcare
  10.3.1 GE Healthcare Company Details
  10.3.2 GE Healthcare Business Overview and Its Total Revenue
  10.3.3 GE Healthcare Nanotechnology in Cancer Treatment Introduction
  10.3.4 GE Healthcare Revenue in Nanotechnology in Cancer Treatment Business (2015-2020)
  10.3.5 GE Healthcare Recent Development
10.4 Sigma-Tau Pharmaceuticals Inc.
  10.4.1 Sigma-Tau Pharmaceuticals Inc. Company Details
  10.4.2 Sigma-Tau Pharmaceuticals Inc. Business Overview and Its Total Revenue
  10.4.3 Sigma-Tau Pharmaceuticals Inc. Nanotechnology in Cancer Treatment Introduction
  10.4.4 Sigma-Tau Pharmaceuticals Inc. Revenue in Nanotechnology in Cancer Treatment Business (2015-2020)
  10.4.5 Sigma-Tau Pharmaceuticals Inc. Recent Development
10.5 Johnson & Johnson
  10.5.1 Johnson & Johnson Company Details
  10.5.2 Johnson & Johnson Business Overview and Its Total Revenue
  10.5.3 Johnson & Johnson Nanotechnology in Cancer Treatment Introduction
  10.5.4 Johnson & Johnson Revenue in Nanotechnology in Cancer Treatment Business (2015-2020)
  10.5.5 Johnson & Johnson Recent Development
10.6 Mallinckrodt Plc
  10.6.1 Mallinckrodt Plc Company Details
  10.6.2 Mallinckrodt Plc Business Overview and Its Total Revenue
  10.6.3 Mallinckrodt Plc Nanotechnology in Cancer Treatment Introduction
  10.6.4 Mallinckrodt Plc Revenue in Nanotechnology in Cancer Treatment Business (2015-2020)
  10.6.5 Mallinckrodt Plc Recent Development
10.7 Merck & Company Inc.
  10.7.1 Merck & Company Inc. Company Details
  10.7.2 Merck & Company Inc. Business Overview and Its Total Revenue
  10.7.3 Merck & Company Inc. Nanotechnology in Cancer Treatment Introduction
  10.7.4 Merck & Company Inc. Revenue in Nanotechnology in Cancer Treatment Business (2015-2020)
  10.7.5 Merck & Company Inc. Recent Development
10.8 Nanosphere Inc.
  10.8.1 Nanosphere Inc. Company Details
  10.8.2 Nanosphere Inc. Business Overview and Its Total Revenue
  10.8.3 Nanosphere Inc. Nanotechnology in Cancer Treatment Introduction
  10.8.4 Nanosphere Inc. Revenue in Nanotechnology in Cancer Treatment Business (2015-2020)
  10.8.5 Nanosphere Inc. Recent Development
10.9 Pfizer, Inc.
  10.9.1 Pfizer, Inc. Company Details
  10.9.2 Pfizer, Inc. Business Overview and Its Total Revenue
  10.9.3 Pfizer, Inc. Nanotechnology in Cancer Treatment Introduction
  10.9.4 Pfizer, Inc. Revenue in Nanotechnology in Cancer Treatment Business (2015-2020)
  10.9.5 Pfizer, Inc. Recent Development
10.10 Celgene Corporation
  10.10.1 Celgene Corporation Company Details
  10.10.2 Celgene Corporation Business Overview and Its Total Revenue
  10.10.3 Celgene Corporation Nanotechnology in Cancer Treatment Introduction
  10.10.4 Celgene Corporation Revenue in Nanotechnology in Cancer Treatment Business (2015-2020)
  10.10.5 Celgene Corporation Recent Development

11 ANALYST'S VIEWPOINTS/CONCLUSIONS

12 APPENDIX

12.1 Research Methodology
  12.1.1 Methodology/Research Approach
  12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Nanotechnology in Cancer Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Nanotechnology in Cancer Treatment Revenue
Table 3. Ranking of Global Top Nanotechnology in Cancer Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Nanotechnology in Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Nanoparticles
Table 6. Key Players of Nanorods
Table 7. Key Players of Nanofibers
Table 8. Key Players of Graphene
Table 9. Key Players of Metal-Organic Frameworks
Table 10. Key Players of Nanobiosensors
Table 11. Key Players of Nanofluidic Devices
Table 12. Key Players of Nanotools
Table 13. Global Nanotechnology in Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Nanotechnology in Cancer Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Nanotechnology in Cancer Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Nanotechnology in Cancer Treatment Market Share by Regions (2015-2020)
Table 17. Global Nanotechnology in Cancer Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Nanotechnology in Cancer Treatment Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Nanotechnology in Cancer Treatment Market Growth Strategy
Table 23. Main Points Interviewed from Key Nanotechnology in Cancer Treatment Players
Table 24. Global Nanotechnology in Cancer Treatment Revenue by Players (2015-2020) (Million US$)
Table 25. Global Nanotechnology in Cancer Treatment Market Share by Players (2015-2020)
Table 26. Global Top Nanotechnology in Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanotechnology in Cancer Treatment as of 2019)
Table 27. Global Nanotechnology in Cancer Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Nanotechnology in Cancer Treatment Product Solution and Service
Table 30. Date of Enter into Nanotechnology in Cancer Treatment Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Nanotechnology in Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 33. Global Nanotechnology in Cancer Treatment Market Size Share by Type (2015-2020)
Table 34. Global Nanotechnology in Cancer Treatment Revenue Market Share by Type (2021-2026)
Table 35. Global Nanotechnology in Cancer Treatment Market Size Share by Application (2015-2020)
Table 36. Global Nanotechnology in Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. Global Nanotechnology in Cancer Treatment Market Size Share by Application (2021-2026)
Table 38. North America Key Players Nanotechnology in Cancer Treatment Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Nanotechnology in Cancer Treatment Market Share (2019-2020)
Table 40. North America Nanotechnology in Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. North America Nanotechnology in Cancer Treatment Market Share by Type (2015-2020)
Table 42. North America Nanotechnology in Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. North America Nanotechnology in Cancer Treatment Market Share by Application (2015-2020)
Table 44. Europe Key Players Nanotechnology in Cancer Treatment Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Nanotechnology in Cancer Treatment Market Share (2019-2020)
Table 46. Europe Nanotechnology in Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Nanotechnology in Cancer Treatment Market Share by Type (2015-2020)
Table 48. Europe Nanotechnology in Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Nanotechnology in Cancer Treatment Market Share by Application (2015-2020)
Table 50. China Key Players Nanotechnology in Cancer Treatment Revenue (2019-2020) (Million US$)
Table 51. China Key Players Nanotechnology in Cancer Treatment Market Share (2019-2020)
Table 52. China Nanotechnology in Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. China Nanotechnology in Cancer Treatment Market Share by Type (2015-2020)
Table 54. China Nanotechnology in Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. China Nanotechnology in Cancer Treatment Market Share by Application (2015-2020)
Table 56. Japan Key Players Nanotechnology in Cancer Treatment Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Nanotechnology in Cancer Treatment Market Share (2019-2020)
Table 58. Japan Nanotechnology in Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Nanotechnology in Cancer Treatment Market Share by Type (2015-2020)
Table 60. Japan Nanotechnology in Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Nanotechnology in Cancer Treatment Market Share by Application (2015-2020)
Table 62. Abbott Laboratories Company Details
Table 63. Abbott Laboratories Business Overview
Table 64. Abbott Laboratories Product
Table 65. Abbott Laboratories Revenue in Nanotechnology in Cancer Treatment Business (2015-2020) (Million US$)
Table 66. Abbott Laboratories Recent Development
Table 67. Combimatrix Corporation Company Details
Table 68. Combimatrix Corporation Business Overview
Table 69. Combimatrix Corporation Product
Table 70. Combimatrix Corporation Revenue in Nanotechnology in Cancer Treatment Business (2015-2020) (Million US$)
Table 71. Combimatrix Corporation Recent Development
Table 72. GE Healthcare Company Details
Table 73. GE Healthcare Business Overview
Table 74. GE Healthcare Product
Table 75. GE Healthcare Revenue in Nanotechnology in Cancer Treatment Business (2015-2020) (Million US$)
Table 76. GE Healthcare Recent Development
Table 77. Sigma-Tau Pharmaceuticals Inc. Company Details
Table 78. Sigma-Tau Pharmaceuticals Inc. Business Overview
Table 79. Sigma-Tau Pharmaceuticals Inc. Product
Table 80. Sigma-Tau Pharmaceuticals Inc. Revenue in Nanotechnology in Cancer Treatment Business (2015-2020) (Million US$)
Table 81. Sigma-Tau Pharmaceuticals Inc. Recent Development
Table 82. Johnson & Johnson Company Details
Table 83. Johnson & Johnson Business Overview
Table 84. Johnson & Johnson Product
Table 85. Johnson & Johnson Revenue in Nanotechnology in Cancer Treatment Business (2015-2020) (Million US$)
Table 86. Johnson & Johnson Recent Development
Table 87. Mallinckrodt Plc Company Details
Table 88. Mallinckrodt Plc Business Overview
Table 89. Mallinckrodt Plc Product
Table 90. Mallinckrodt Plc Revenue in Nanotechnology in Cancer Treatment Business (2015-2020) (Million US$)
Table 91. Mallinckrodt Plc Recent Development
Table 92. Merck & Company Inc. Company Details
Table 93. Merck & Company Inc. Business Overview
Table 94. Merck & Company Inc. Product
Table 95. Merck & Company Inc. Revenue in Nanotechnology in Cancer Treatment Business (2015-2020) (Million US$)
Table 96. Merck & Company Inc. Recent Development
Table 97. Nanosphere Inc. Business Overview
Table 98. Nanosphere Inc. Product
Table 99. Nanosphere Inc. Company Details
Table 100. Nanosphere Inc. Revenue in Nanotechnology in Cancer Treatment Business (2015-2020) (Million US$)
Table 101. Nanosphere Inc. Recent Development
Table 102. Pfizer, Inc. Company Details
Table 103. Pfizer, Inc. Business Overview
Table 104. Pfizer, Inc. Product
Table 105. Pfizer, Inc. Revenue in Nanotechnology in Cancer Treatment Business (2015-2020) (Million US$)
Table 106. Pfizer, Inc. Recent Development
Table 107. Celgene Corporation Company Details
Table 108. Celgene Corporation Business Overview
Table 109. Celgene Corporation Product
Table 110. Celgene Corporation Revenue in Nanotechnology in Cancer Treatment Business (2015-2020) (Million US$)
Table 111. Celgene Corporation Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Nanotechnology in Cancer Treatment Market Share by Type: 2020 VS 2026
Figure 2. Nanoparticles Features
Figure 3. Nanorods Features
Figure 4. Nanofibers Features
Figure 5. Graphene Features
Figure 6. Metal-Organic Frameworks Features
Figure 7. Nanobiosensors Features
Figure 8. Nanofluidic Devices Features
Figure 9. Nanotools Features
Figure 10. Global Nanotechnology in Cancer Treatment Market Share by Application: 2020 VS 2026
Figure 11. Cancer Detection Case Studies
Figure 12. Imaging Case Studies
Figure 13. Drug Delivery Case Studies
Figure 14. Radiotherapy Case Studies
Figure 15. Immunotherapy Case Studies
Figure 16. Phototherapy Case Studies
Figure 17. Nanotechnology in Cancer Treatment Report Years Considered
Figure 18. Global Nanotechnology in Cancer Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 19. Global Nanotechnology in Cancer Treatment Market Share by Regions: 2020 VS 2026
Figure 20. Global Nanotechnology in Cancer Treatment Market Share by Regions (2021-2026)
Figure 21. Porter's Five Forces Analysis
Figure 22. Global Nanotechnology in Cancer Treatment Market Share by Players in 2019
Figure 23. Global Top Nanotechnology in Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanotechnology in Cancer Treatment as of 2019
Figure 24. The Top 10 and 5 Players Market Share by Nanotechnology in Cancer Treatment Revenue in 2019
Figure 25. North America Nanotechnology in Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Europe Nanotechnology in Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. China Nanotechnology in Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Japan Nanotechnology in Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Abbott Laboratories Revenue Growth Rate in Nanotechnology in Cancer Treatment Business (2015-2020)
Figure 31. Combimatrix Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Combimatrix Corporation Revenue Growth Rate in Nanotechnology in Cancer Treatment Business (2015-2020)
Figure 33. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. GE Healthcare Revenue Growth Rate in Nanotechnology in Cancer Treatment Business (2015-2020)
Figure 35. Sigma-Tau Pharmaceuticals Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Sigma-Tau Pharmaceuticals Inc. Revenue Growth Rate in Nanotechnology in Cancer Treatment Business (2015-2020)
Figure 37. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Johnson & Johnson Revenue Growth Rate in Nanotechnology in Cancer Treatment Business (2015-2020)
Figure 39. Mallinckrodt Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Mallinckrodt Plc Revenue Growth Rate in Nanotechnology in Cancer Treatment Business (2015-2020)
Figure 41. Merck & Company Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Merck & Company Inc. Revenue Growth Rate in Nanotechnology in Cancer Treatment Business (2015-2020)
Figure 43. Nanosphere Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Nanosphere Inc. Revenue Growth Rate in Nanotechnology in Cancer Treatment Business (2015-2020)
Figure 45. Pfizer, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Pfizer, Inc. Revenue Growth Rate in Nanotechnology in Cancer Treatment Business (2015-2020)
Figure 47. Celgene Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Celgene Corporation Revenue Growth Rate in Nanotechnology in Cancer Treatment Business (2015-2020)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation